[(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid

C22H34N2O6 — CID 70430528

IUPAC[(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid
SMILESCOc1ccc(CN2C(C(C)(C)C)[C@H](NC(=O)O)[C@H]2C2COC(C)(C)O2)c(OC)c1
InChIInChI=1S/C22H34N2O6/c1-21(2,3)19-17(23-20(25)26)18(16-12-29-22(4,5)30-16)24(19)11-13-8-9-14(27-6)10-15(13)28-7/h8-10,16-19,23H,11-12H2,1-7H3,(H,25,26)/t16?,17-,18-,19?/m1/s1
InChIKeySGUBJHIECBKUKU-QGLXBCBXSA-N
MW422.52 g/mol
LogP3.09
Rot. Bonds6

About [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid

[(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid (PubChem CID 70430528) has the molecular formula C22H34N2O6 and a molecular weight of 422.52 g/mol. Its IUPAC name is [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid.

Molecular Properties

Compound Name[(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid
PubChem CID70430528
Molecular FormulaC22H34N2O6
Molecular Weight422.52 g/mol
Exact Mass422.24
IUPAC Name[(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid
SMILESCOc1ccc(CN2C(C(C)(C)C)[C@H](NC(=O)O)[C@H]2C2COC(C)(C)O2)c(OC)c1
InChIInChI=1S/C22H34N2O6/c1-21(2,3)19-17(23-20(25)26)18(16-12-29-22(4,5)30-16)24(19)11-13-8-9-14(27-6)10-15(13)28-7/h8-10,16-19,23H,11-12H2,1-7H3,(H,25,26)/t16?,17-,18-,19?/m1/s1
InChIKeySGUBJHIECBKUKU-QGLXBCBXSA-N
XLogP3.09
TPSA89.49 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500422.52
LogP ≤ 53.09
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid?
The IUPAC name of [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid (CID 70430528) is [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid.
What is the SMILES notation for [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid?
The canonical SMILES for [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid is COc1ccc(CN2C(C(C)(C)C)[C@H](NC(=O)O)[C@H]2C2COC(C)(C)O2)c(OC)c1.
What is the InChIKey of [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid?
The InChIKey is SGUBJHIECBKUKU-QGLXBCBXSA-N. The full InChI is InChI=1S/C22H34N2O6/c1-21(2,3)19-17(23-20(25)26)18(16-12-29-22(4,5)30-16)24(19)11-13-8-9-14(27-6)10-15(13)28-7/h8-10,16-19,23H,11-12H2,1-7H3,(H,25,26)/t16?,17-,18-,19?/m1/s1.
What are the key properties of [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid?
[(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid has a molecular weight of 422.52 g/mol, XLogP of 3.09, 6 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,4S)-2-tert-butyl-1-[(2,4-dimethoxyphenyl)methyl]-4-(2,2-dimethyl-1,3-dioxolan-4-yl)azetidin-3-yl]carbamic acid is sourced from PubChem (CID 70430528), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).